Commonwealth Cancer Consortium Inc

Break Through Cancer

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 851681659 ✦ Cambridge, MA ✦ Designated as a 501(c)(3)

Overview

What is Commonwealth Cancer Consortium Inc?

The Commonwealth Cancer Consortium Inc is a Boston-based nonprofit organization dedicated to advancing cancer research and finding cures for some of the most complex and challenging diseases. They collaborate with five top cancer research centers, including Dana-Farber Cancer Institute, the Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Massachusetts Institute of Technology's Koch Institute for Integrative Cancer Research, the University of Texas MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center. Their mission is to support multidisciplinary research teams, focusing on diagnosing, treating, and ideally curing difficult-to-treat cancers. With a team of 14 dedicated individuals, they aim to make a significant impact in the field of cancer research and provide hope for patients and their families.


Official website here: www.breakthroughcancer.org

Is Commonwealth Cancer Consortium Inc legitimate?

Commonwealth Cancer Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Commonwealth Cancer Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $1,280,731
Professional Fundraising Fees: $0
Other Salaries and Wages: $765,845

For more financial information, click here


Official website here: www.breakthroughcancer.org

What is the mission statement of Commonwealth Cancer Consortium Inc?

The Commonwealth Cancer Consortium Inc is a foundation dedicated to advancing translational research in some of the most challenging to treat cancers. With partner organizations that are leading cancer research centers, the consortium brings together brilliant and creative minds in the country. They embrace a scientific movement that accepts nothing less than multidisciplinary collaboration in patient-centric cancer research. Working closely with teams of scientists, engineers, and clinical researchers, they focus on diagnosing, treating, and ideally curing intractable forms of cancer. Despite advancements in research and technology, many patients have been left behind, and there are cancers where progress remains stagnant. The Commonwealth Cancer Consortium is committed to making headway in these complex and challenging diseases and finding hope for patients and their families.


Official website here: www.breakthroughcancer.org

Who is the CEO of Commonwealth Cancer Consortium Inc?

William Hulme is the Director of Commonwealth Cancer Consortium Inc.


Official website here: www.breakthroughcancer.org

What is the revenue of Commonwealth Cancer Consortium Inc?

Commonwealth Cancer Consortium Inc's revenue in 2022 was $27,161,244.


Official website here: www.breakthroughcancer.org

Who are the executives of Commonwealth Cancer Consortium Inc and what are their salaries?

The average compensation at Commonwealth Cancer Consortium Inc during 2022 was $146,184. There are 14 employees and 13 volunteers at Commonwealth Cancer Consortium Inc.

Here are 19 key members and their salaries:

    Lisa Schwarz (Coo/Cpo/Secretary)
  • Compensation: $255,235
  • Related: $0
  • Other: $39,083

    • Jesse Boehm (Chief Science Officer)
  • Compensation: $240,482
  • Related: $0
  • Other: $38,482

    • Tyler Jacks (President)
  • Compensation: $250,000
  • Related: $0
  • Other: $13,190

    • Kari Mchugh (Chief Communications Officer)
  • Compensation: $187,913
  • Related: $0
  • Other: $28,204

    • William Hulme (Cfo/Treasurer)
  • Compensation: $201,275
  • Related: $0
  • Other: $10,738

    • Micheal Noble (Chief Data Officer)
  • Compensation: $145,826
  • Related: $0
  • Other: $16,954

    • Bill Goodwin (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Alice Goodwin (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • John Sherman (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Susan Hockfield (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Giulio Draetta (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David Jaffray (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bill Nelson (Chairman) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David Scheinberg (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Craig Thompson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lisa Deangelis (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Laurie Glimcher (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Bill Hahn (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Liz Jaffee (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.breakthroughcancer.org

    Where can I find the form 990 for Commonwealth Cancer Consortium Inc?

    The Commonwealth Cancer Consortium Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.breakthroughcancer.org

    Learn more at the official website: www.breakthroughcancer.org

    Mission Statement of Commonwealth Cancer Consortium Inc

    Commonwealth Cancer Consortium Inc, a foundation dedicated to making a significant impact on some of the most challenging and complex cancers, believes in the power of collaboration and the importance of translational research. With a mission that accepts nothing less than multi-institutional collaboration in patient-centric cancer research, this organization brings together some of the most brilliant and creative minds from top cancer research centers across the country.

    The foundation is committed to staying at the forefront of scientific advancements in diagnosing, treating, and ideally curing cancers that have left many patients behind. While advancements in research and technology have benefited many, there are still too many cancers where the needle remains unmoved. Break Through Cancer, as the organization is called, is determined to make headway in these intricate and difficult diseases and to provide hope for patients and their families.

    Working closely with teams of scientists, engineers, and clinical researchers, Commonwealth Cancer Consortium Inc focuses its efforts on the most difficult to treat cancers. The foundation's vision is rooted in the belief that by combining resources, knowledge, and expertise, they can make a real difference in the lives of those affected by these complex diseases. Through their unwavering commitment to patient-centric research and collaboration, Commonwealth Cancer Consortium Inc continues to push the boundaries of what is possible in the fight against cancer.

    Impact

    This information is meant to be a general summary of Commonwealth Cancer Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    Commonwealth Cancer Consortium Inc, through its foundation Break Through Cancer, is making a significant impact by supporting translational research in the most difficult to treat cancers. This nonprofit provides funding to teams of researchers from top cancer research centers to help intercept cancer early, develop more effective treatments, and accelerate cures for some of the deadliest cancers. By fostering multi-institutional collaboration and focusing on patient-centric cancer research, Commonwealth Cancer Consortium Inc is dedicated to finding hope for patients and their families affected by intractable forms of cancer.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $3,199
  • Program Service Revenue: $0
  • Gross Receipts: $27,161,244

    • Assets and Liabilities:
  • Total Assets: $102,328,231
  • Total Liabilities: $1,254,932
  • Net Assets: $101,073,299
  • Organization Details

    Founding Year

    2020

    Principal Officer

    William Hulme

    Main Address

    101 ROGERS STREET, CAMBRIDGE, MA, 02142

    If you are a representative of Commonwealth Cancer Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.